 4. No prior chemotherapy for recurrent andor metastatic disease prior adjuvantneoadjuvant chemotherapy is allowed at least 6 months has relapsed between completion of adjuvantneoadjuvant therapy and enrolment into the therapy; prior S-1 or capecitabine is not allowed 